Ninety percent of cancer-related deaths are due to metastatic (stage IV) disease, when the malignant cells spread throughout the body interfering with organ function leading to organ failure and death.

Combining our state-of-the-art cell-based technologies with innovative diagnostic, prognostic, and drug development strategies, Ixchel Scientific is developing comprehensive interventions to combat metastatic cancers.